Minerva Surgica "announced that it has entered into a share purchase agreement for the sale of 146,627,565 shares of its common stock in a private placement, led by Accelmed, with participation by New Enterprise Associates, at an offering price of $0.2046 per share. Following the offering, Accelmed will become the controlling stockholder of Minerva Surgical. Gross proceeds of the private placement are expected to be approximately $30 million, before deducting placement agent fees and other expenses payable by Minerva Surgical. Piper Sandler is acting as sole placement agent for the private placement. The private placement is expected to close in the first quarter of 2023 subject to the satisfaction of customary closing conditions and approval of the private placement by the Minerva Surgical stockholders. It is a condition to closing that the Company’s Board of Directors be composed of a majority of directors designated by AccelMed."
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on UTRS:
- Minerva Surgical Announces Retirement of CEO David Clapper and Appointment of Todd Usen as Company President and CEO
- Why Minerva Surgical (NASDAQ:UTRS) Stock is Rallying?
- Minerva Surgical Announces $30 Million Private Placement of Common Stock Led by Accelmed Partners
- Minerva Surgical Reports Third Quarter 2022 Financial Results
- Minerva Surgical Announces Change of Date for Third Quarter 2022 Earnings Release and Conference Call